JPMorgan Chase & Co. lessened its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 64.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,222 shares of the company's stock after selling 201,892 shares during the quarter. JPMorgan Chase & Co. owned 0.20% of Molina Healthcare worth $32,953,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Versant Capital Management Inc raised its stake in shares of Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. acquired a new position in Molina Healthcare during the fourth quarter worth about $52,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after purchasing an additional 88 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its position in shares of Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after purchasing an additional 155 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd grew its position in shares of Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after purchasing an additional 179 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the company. UBS Group reduced their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a research note on Friday. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Stephens reaffirmed an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a research note on Thursday, February 6th. Finally, Guggenheim started coverage on shares of Molina Healthcare in a research report on Wednesday. They issued a "neutral" rating for the company. Seven investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $355.75.
View Our Latest Report on Molina Healthcare
Insider Activity at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.10% of the company's stock.
Molina Healthcare Trading Up 0.8 %
Shares of Molina Healthcare stock traded up $2.62 during trading hours on Friday, reaching $345.30. The stock had a trading volume of 661,970 shares, compared to its average volume of 653,643. The firm has a market capitalization of $18.89 billion, a price-to-earnings ratio of 16.90, a P/E/G ratio of 1.06 and a beta of 0.70. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $378.92. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a 50 day simple moving average of $310.39 and a two-hundred day simple moving average of $308.18.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
